From symptom discovery to treatment - women's pathways to breast cancer care: a cross-sectional study
- PMID: 29562894
- PMCID: PMC5863383
- DOI: 10.1186/s12885-018-4219-7
From symptom discovery to treatment - women's pathways to breast cancer care: a cross-sectional study
Abstract
Background: Typically, women in South Africa (SA) are diagnosed with breast cancer when they self-present with symptoms to health facilities. The aim of this study was to determine the pathway that women follow to breast cancer care and factors associated with this journey.
Methods: A cross-sectional study was conducted at a tertiary hospital in the Western Cape Province, SA, between May 2015 and May 2016. Newly diagnosed breast cancer patients were interviewed to determine their socio-demographic profile; knowledge of risk factors, signs and symptoms; appraisal of breast changes; clinical profile and; key time events in the journey to care. The Model of Pathways to Treatment Framework underpinned the analysis. The total time (TT) between a woman noticing the first breast change and the date of scheduled treatment was divided into 3 intervals: the patient interval (PI); the diagnostic interval (DI) and the pre-treatment interval (PTI). For the PI, DI and PTI a bivariate comparison of median time intervals by various characteristics was conducted using Wilcoxon rank-sum and Kruskal-Wallis tests. Cox Proportional-Hazards models were used to identify factors independently associated with the PI, DI and PTI.
Results: The median age of the 201 participants was 54 years, and 22% presented with late stage disease. The median TT was 110 days, with median patient, diagnostic and pre-treatment intervals of 23, 28 and 37 days respectively. Factors associated with the PI were: older age (Hazard ratio (HR) 0.59, 95% CI 0.40-0.86), initial symptom denial (HR 0.43, 95% CI 0.19-0.97) and waiting for a lump to increase in size before seeking care (HR 0.51, 95% CI 0.33-0.77). Women with co-morbidities had a significantly longer DI (HR 0.67, 95% CI 0.47-0.96) as did women who mentioned denial of initial breast symptoms (HR 4.61, 95% CI 1.80-11.78). The PTI was associated with late stage disease at presentation (HR 1.78, 95% CI 1.15-2.76).
Conclusion: The Model of Pathways to Treatment provides a useful framework to explore patient's journeys to care and identified opportunities for targeted interventions.
Keywords: Breast cancer; Breast cancer knowledge; Cancer symptoms; Delay in diagnosis; South Africa; Timely diagnosis.
Conflict of interest statement
Competing interest
The authors declare that they have no competing interests.
Ethics approval and consent to participate
Ethical approval to conduct the study was obtained from the Human Research Ethics Committee, University of Cape Town (Reference number 313/2013). Written informed consent was obtained from all participants.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Understanding pathways to breast cancer diagnosis among women in the Western Cape Province, South Africa: a qualitative study.BMJ Open. 2016 Jan 4;6(1):e009905. doi: 10.1136/bmjopen-2015-009905. BMJ Open. 2016. PMID: 26729392 Free PMC article.
-
Women's appraisal, interpretation and help-seeking for possible symptoms of breast and cervical cancer in South Africa: a qualitative study.BMC Womens Health. 2020 Nov 13;20(1):251. doi: 10.1186/s12905-020-01120-4. BMC Womens Health. 2020. PMID: 33187501 Free PMC article.
-
Assessing the level of breast cancer awareness among recently diagnosed patients in Ain Shams University Hospital.Breast. 2013 Dec;22(6):1210-4. doi: 10.1016/j.breast.2013.08.010. Epub 2013 Sep 19. Breast. 2013. PMID: 24054904
-
Delayed Presentation, Diagnosis, and Treatment of Breast Cancer Among Chinese Women: An Integrative Literature Review.Cancer Nurs. 2023 May-Jun 01;46(3):217-232. doi: 10.1097/NCC.0000000000001074. Epub 2022 Mar 11. Cancer Nurs. 2023. PMID: 35283469 Review.
-
Prevalence of Themes Linked to Delayed Presentation of Breast Cancer in Africa: A Meta-Analysis of Patient-Reported Studies.JCO Glob Oncol. 2020 May;6:731-742. doi: 10.1200/JGO.19.00402. JCO Glob Oncol. 2020. PMID: 32437263 Free PMC article. Review.
Cited by
-
Determinants of late detection and advanced-stage diagnosis of breast cancer in Nigeria.PLoS One. 2021 Nov 3;16(11):e0256847. doi: 10.1371/journal.pone.0256847. eCollection 2021. PLoS One. 2021. PMID: 34731161 Free PMC article.
-
Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study.Fam Pract. 2022 Jul 19;39(4):639-647. doi: 10.1093/fampra/cmab155. Fam Pract. 2022. PMID: 34871389 Free PMC article.
-
Vascular Endothelial Growth Factor Ligands and Receptors in Breast Cancer.J Clin Med. 2023 Mar 21;12(6):2412. doi: 10.3390/jcm12062412. J Clin Med. 2023. PMID: 36983412 Free PMC article. Review.
-
Development and validation of the African Women Awareness of CANcer (AWACAN) tool for breast and cervical cancer.PLoS One. 2019 Aug 6;14(8):e0220545. doi: 10.1371/journal.pone.0220545. eCollection 2019. PLoS One. 2019. PMID: 31386684 Free PMC article.
-
Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil.Oncologist. 2022 May 6;27(5):344-351. doi: 10.1093/oncolo/oyac050. Oncologist. 2022. PMID: 35348756 Free PMC article.
References
-
- South African National Cancer Registry. Johannesburg; 2017. www.ncr.ac.za. Accessed 30 September 2017.
-
- South African National Department of Health . Breast cancer: prevention and control policy. 2017. pp. 1–113.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous